Medical Communications

The Centre for Process Innovation is targeting small and medium-sized enterprises from the pharmaceutical and chemical industries with its Innovation …

We’re now into 2017 in earnest and news of acquisitions, partnerships, R&D advancements and scandals are back in force. Cancer …

Mauricio Futran, vice president, Process Sciences, Janssen Supply Chain, discusses, in the latest issue of Pharmafile, Janssen’s move into continuous …

Eli Lilly has successfully won a major patent case against Teva Pharmaceuticals, with the case being decided at the US …

In a reappraisal decision by NICE, everolimus (Novartis’ Afinitor) has been recommended for the treatment of advanced renal cell carcinoma …

The Welsh Government has created a five-year £80 million drug fund, which will work out to an additional £16 million …

The Mylan EpiPen scandal was one of last year’s most closely-followed stories, as the industry reacted with scorn to CEO …

IBM Watson Health has agreed a research initiative with the FDA to develop and test the exchange of patients’ health …

Shire Pharmaceuticals is set to pay a $350 million settlement over accusations that it had bribed clinicians and physicians by …

Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the …

MSD, known as Merck in North America, and Eli Lilly have announced the expansion of their existing immuno-oncology collaboration. The …

MPS has extended its range of child resistant packs. These patented designs offer maximum flexibility and can be customised to …

As part of the wider ‘cancer moonshot’ initiative, confirmed by the signing of the 21st Century Cures Act by Obama, …

The FDA regulator has publicly announced that there are safety issues with certain of St. Jude’s medical devices, including cardiac …

Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its …